Simulations Plus dipped after Q3 2025 on guidance cuts, but core software strength and long-term growth drivers remain. Find ...

Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...

Quest Diagnostics (DGX) is a strong buy with growth potential, solid margins, and dividend increases. Discover the full ...

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...

SIGNIFICANT EVENTS DURING 1 APRIL - 30 JUNE 2025In April, Iconovo announced an organizational change expected to reduce annual costs by approximately 14-16 MSEK starting in the third quarter of 2025.

Dr. Robert Fuller leaves a legacy at UConn Health and beyond Dr. Robert Fuller (pictured in 2021) is retired from 30 years of ...

Real-time urine drug test data accurately estimate overdose deaths, which could help primary care providers evaluate their community’s health and the effectiveness of interventions, according to an ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Hopkins expert Thomas Hartung discusses an announcement by the nation's largest biomedical research funder that it will no longer consider grant proposals that do not include alternative testing model ...